{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-182802","form_type":"8-K","ticker":"ALGS","cik":"0001799448","company_name":"Aligos Therapeutics, Inc.","filed_at":"2022-06-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.360094+00:00","generated_at":"2026-06-24T23:01:04.661402+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Aligos Therapeutics reports annual meeting vote results; directors elected, auditor ratified","bullets":["Elected Class II directors: Thomas Woiwode (21.3M for, 4.2M withheld), Leonid Beigelman (21.5M for, 4.0M withheld), K. Peter Hirth (21.9M for, 3.6M withheld).","Ratification of Ernst & Young as auditor for FY2022 passed with 29.5M for, 90k against, 125 abstentions.","Broker non-votes of ~4.0M shares on director election."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-182802","json":"https://secwatch.observer/filing/0001193125-22-182802.json","markdown":"https://secwatch.observer/filing/0001193125-22-182802.md","text":"https://secwatch.observer/filing/0001193125-22-182802.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799448/000119312522182802/0001193125-22-182802-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799448/000119312522182802/d356477d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T23:01:04.661402+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}